Loading

Going It Alone...or Together? A Worldview Panel

June 19, 2025
Special Program
Special Program
Main Stage
Are the nationalist trends toward investment, trade and national security policies going to divide the world into different spheres of R&D and access to health care products? What impact will they have on global research, cross-border collaboration, and access to healthcare products and public health? The Balkanization of science, knowledge and discovery may have profound impacts on what has traditionally been a collective, global effort. Panel developed in conjunction with Scientific American and Springer Nature publications.
Moderator
Joseph Damond
Chair, International Trade Policy & Global Life Sciences
Crowell Global Advisors
Speakers
Anthony Japour, MD
CEO and President
iTolerance, Inc.
Bibhash Mukhopadhyay, PhD
Venture Capital Investor
Michael Nally
CEO-Partner at Flagship Pioneering and Chief Executive Officer
Generate:Biomedicines
Jennifer Sheng
Head of Healthcare Equity Capital Markets
Citi
Erika Smith
CEO
EpiTET Therapeutics
Steffen Thirstrup, MD, PhD
Chief Medical Officer
European Medicines Agency (EMA)
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS